Related Experiment Video
Updated: Jul 10, 2026

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
Published on: October 26, 2018
Species B adenovirus serotypes 3, 7, 11 and 35 share similar binding sites on the membrane cofactor protein CD46
Christoph Fleischli1, Dominique Sirena1, Guillaume Lesage1
1Institute of Molecular Biology, University of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.
Abstract:
We recently characterized the domains of the human cofactor protein CD46 involved in binding species B2 adenovirus (Ad) serotype 35. Here, the CD46 binding determinants are mapped for the species B1 Ad serotypes 3 and 7 and for the species B2 Ad11. Ad3, 7 and 11 bound and transduced CD46-positive rodent BHK cells at levels similar to Ad35. By using antibody-blocking experiments, hybrid CD46-CD4 receptor constructs and CD46 single point mutants, it is shown that Ad3, 7 and 11 share many of the Ad35-binding features on CD46. Both CD46 short consensus repeat domains SCR I and SCR II were necessary and sufficient for optimal binding and transgene expression, provided that they were positioned at an appropriate distance from the cell membrane. Similar to Ad35, most of the putative binding residues of Ad3, 7 and 11 were located on the same glycan-free, solvent-exposed face of the SCR I or SCR II domains, largely overlapping with the binding surface of the recently solved fiber knob Ad11-SCR I-II three-dimensional structure. Differences between species B1 and B2 Ads were documented with competition experiments based on anti-CD46 antibodies directed against epitopes flanking the putative Ad-binding sites, and with competition experiments based on soluble CD46 protein. It is concluded that the B1 and B2 species of Ad engage CD46 through similar binding surfaces.
Insights
Species B1 and B2 adenoviruses (Ads) bind to human CD46 using similar surface domains. This study maps the specific CD46 binding sites for Ad serotypes 3, 7, and 11, revealing conserved interactions.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Human cofactor protein CD46 serves as a receptor for certain adenovirus (Ad) serotypes.
- Previous studies characterized CD46 binding for species B2 Ad serotype 35.
Purpose of the Study:
- To map the CD46 binding determinants for species B1 Ad serotypes 3 and 7, and species B2 Ad11.
- To compare the CD46 binding mechanisms of different adenovirus species.
Main Methods:
- Antibody-blocking experiments were employed to identify binding sites.
- Hybrid CD46-CD4 receptor constructs were utilized to analyze domain interactions.
- Single point mutations in CD46 were generated to pinpoint critical binding residues.
- Competition experiments with anti-CD46 antibodies and soluble CD46 protein were performed.
Main Results:
- Adenovirus serotypes 3, 7, and 11 bound and transduced CD46-positive cells similarly to Ad35.
- Both CD46 short consensus repeat domains (SCR I and SCR II) were essential and sufficient for optimal Ad binding and transgene expression.
- Putative binding residues for Ad3, 7, and 11 were located on a similar face of SCR I or SCR II, overlapping with the Ad11-CD46 structure.
- Differences in binding between species B1 and B2 Ads were observed through competition assays.
Conclusions:
- Species B1 and B2 adenoviruses engage CD46 through largely conserved binding surfaces.
- The SCR I and SCR II domains of CD46 are critical for binding multiple adenovirus serotypes.
- Structural and functional similarities exist in CD46-adenovirus interactions across different species.
More Related Videos
13:36Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
10:22Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells
Published on: November 12, 2015
Related Concept Videos
Respiratory Syncytial Virus Disease
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Coronavirus
Inhibitors Of Virion Release
Structure of Cadherins